Identifying and targeting cancer vulnerabilities is crucial because it allows for the development of more effective and personalized treatments. By honing in on specific weaknesses in cancer cells, therapies can be designed to attack these cells without harming normal tissues, leading to fewer side effects and better patient outcomes.
